My watch list
my.bionity.com  
Login  

Pharmaceutical publication planning



Pharmaceutical publication planning is the activity of planning the dissemination of scientific and clinical data on a drug to healthcare professionals at scientific congresses and medical society meetings and in peer-reviewed medical journals. The purpose of pharmaceutical publication planning is to ensure that professionals involved in the care of patients have the scientific and clinical data necessary to learn about and use a drug in a safe and effective manner. It involves developing a detailed plan that outlines the timely presentation of the scientific and clinical data to appropriate types of healthcare professionals (such as physicians, pharmacists, nurses) as a drug undergoes clinical development and after it is marketed. Because of scientific and therapeutic advances, pharmaceutical publication planning has become a well-established and important function by pharmaceutical companies in order to educate healthcare professionals accordingly about new drugs and marketed drugs with new clinical uses or safety information. At pharmaceutical companies, publication planning is usually overseen by medical or clinical affairs professionals. In this effort, pharmaceutical companies frequently use the assistance of medical communication companies with publication planning expertise and professional medical writers.

Pharmaceutical publication planning organizations

Professional organizations for individuals involved in pharmaceutical publication planning include the International Society of Medical Publication Professionals (ISMPP) and The International Publication Planning Association (TIPPA). The purpose of these organizations is to create a forum where individuals involved with pharmaceutical publication planning and biomedical publications can meet and share knowledge and experience. They serve to promote career opportunities and professional development of individuals involved with pharmaceutical publication planning, as well as to promote standards of excellence in ethical professional medical writing and the biomedical publication process in disseminating scientific and clinical data on pharmaceutical products.

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Pharmaceutical_publication_planning". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE